search
Back to results

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

Primary Purpose

Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Multimodal intervention consisting of four core components
Standard of care
Sponsored by
The Hospital for Sick Children
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Inflammatory Bowel Diseases focused on measuring Transition from Pediatric to Adult Care, Health Services Research, Adolescent Medicine

Eligibility Criteria

16 Years - 17 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Aged 16-17.5 years
  • Diagnosed with IBD diagnosed using standard criteria
  • Ability to speak/read English at a functional (Grade 8) level
  • Intention to reside in Canada after transfer to adult care
  • Ability to use a smartphone or personal computer for the virtual intervention

Exclusion Criteria:

  • Do not speak English fluently
  • Intention to leave Canada after graduation from high school

Sites / Locations

  • BC Children's Hospital
  • McMaster Children's Hospital
  • Children's Hospital of Eastern OntarioRecruiting
  • The Hospital for Sick ChildrenRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Intervention: Multimodal intervention consisting of four core components.

Control: Standard of care

Arm Description

Core Component 1: Individualized Assessment Core Component 2: Transition Facilitation with a Navigator Core Component 3: Participant Skills-building Core Component 4: Structured Educational eLearning Curriculum

Routine Care

Outcomes

Primary Outcome Measures

IBD Disability Index (IBD-DI)
Ordinal variable that measures participant functioning as the primary outcome. IBD-DI was selected as a validated measure of overall disability, functioning, and health. The primary outcome will be measured 3 years after enrollment.

Secondary Outcome Measures

Transition Readiness Assessment Questionnaire (TRAQ)
Transition Readiness
Transition Readiness Assessment Questionnaire (TRAQ)
Transition Readiness
Transition Success Scores (TSS)
Transition Readiness
Transition Success Scores (TSS)
Transition Readiness
Pediatric IBD INTERMED
Biopsychosocial Risk Profile
Pediatric IBD INTERMED
Biopsychosocial Risk Profile
IBD-KID2
Disease-related knowledge
IBD-KID2
Disease-related knowledge
IBDQ-32
Quality of life
IBDQ-32
Quality of life
IBD Self-Efficacy Scale - Adolescent (IBD-SES-A)
Self-Efficacy
IBD Self-Efficacy Scale - Adolescent (IBD-SES-A)
Self-Efficacy
Physician Global Assessment (PGA)
Physician assessment of disease activity
Physician Global Assessment (PGA)
Physician assessment of disease activity
Fecal calprotectin
Measure of gut inflammation
Modified Harvey-Bradshaw Index (HBI) for Crohn's disease
Disease activity in Crohn's disease patients
Modified Harvey-Bradshaw Index (HBI) for Crohn's disease
Disease activity in Crohn's disease patients
Pediatric Ulcerative Colitis Activity Index (PUCAI)
Disease activity in ulcerative colitis patients
Pediatric Ulcerative Colitis Activity Index (PUCAI)
Disease activity in ulcerative colitis patients
Emergency department visit after 18th birthday (yes/no)
Health services utilization
Number of emergency department visits after 18th birthday
Health services utilization
Hospitalization after 18th birthday (yes/no)
Health services utilization
Number of outpatient visits to a gastroenterologist after 18th birthday
Health services utilization
IBD Disability Index (IBD-DI)
Ordinal variable that measures participant functioning as the primary outcome. IBD-DI was selected as a validated measure of overall disability, functioning, and health.

Full Information

First Posted
January 10, 2022
Last Updated
April 10, 2023
Sponsor
The Hospital for Sick Children
Collaborators
Crohn's and Colitis Canada, The Leona M. and Harry B. Helmsley Charitable Trust, The Canadian Children Inflammatory Bowel Disease Network: A Partnership with the CH.I.L.D. Foundation, The CH.I.L.D. Foundation - Children with Intestinal & Liver Disorders
search

1. Study Identification

Unique Protocol Identification Number
NCT05221281
Brief Title
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Official Title
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 25, 2022 (Actual)
Primary Completion Date
July 1, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
The Hospital for Sick Children
Collaborators
Crohn's and Colitis Canada, The Leona M. and Harry B. Helmsley Charitable Trust, The Canadian Children Inflammatory Bowel Disease Network: A Partnership with the CH.I.L.D. Foundation, The CH.I.L.D. Foundation - Children with Intestinal & Liver Disorders

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: Transition in care is defined as the "purposeful and planned movement of adolescents and young adults with a chronic medical condition from pediatric to adult-oriented healthcare systems/care providers." Currently, there is no Level 1 evidence of an intervention to improve the care of transitioning adolescents and young adults (AYAs) with inflammatory bowel disease (IBD). The development of a transition program using a biopsychosocial approach will improve the standards for healthcare delivery to transitioning IBD patients. This is a protocol for a structured randomized controlled trial (RCT) to assess the efficacy and impact of a multimodal intervention focused on improving patient function, transition readiness and outcomes among AYA patients with IBD being cared for at pediatric centers in Canada. Methods: This multi-center RCT is a type 1 hybrid effectiveness-implementation trial to evaluate effectiveness of the intervention and how it can be implemented more widely after the trial. We will include patients aged 16.0 to 17.5 years. The intervention program consists of 4 core components: 1) individualized assessment, 2) transition navigator, 3) virtual patient skills-building with a focus on building resilience, self-management and self-efficacy, and 4) a virtual structured education program. The control group will undergo standard-of-care defined by each participating center. The primary outcome will be the IBD Disability Index, a validated measure to assess patient functioning. Secondary outcomes include transition readiness, anxiety and depression scales, and health service utilization rates. Additionally, we will identify the effectiveness of an evidence-based implementation approach and related barriers and facilitators for the intervention program. Discussion: The type 1 hybrid effectiveness-implementation design will allow us to develop a feasible, sustainable, and acceptable final intervention model. The intervention will consist of modules that can be accessed in an online, virtual platform. The implementation will not depend on individual hospital resources, allowing centralization of interventions and funding. The authors anticipate that the main study limitation will relate to study subjects not completely adhering to every component of the intervention, which will be evaluated and addressed using the implementation science approach.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammatory Bowel Diseases, Crohn Disease, Ulcerative Colitis, Adolescent Development, Transition, Mental Health Wellness 1
Keywords
Transition from Pediatric to Adult Care, Health Services Research, Adolescent Medicine

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
115 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention: Multimodal intervention consisting of four core components.
Arm Type
Experimental
Arm Description
Core Component 1: Individualized Assessment Core Component 2: Transition Facilitation with a Navigator Core Component 3: Participant Skills-building Core Component 4: Structured Educational eLearning Curriculum
Arm Title
Control: Standard of care
Arm Type
Other
Arm Description
Routine Care
Intervention Type
Behavioral
Intervention Name(s)
Multimodal intervention consisting of four core components
Intervention Description
Core Component 1: Individualized Assessment: Each participant will undergo individualized assessment of their biopsychosocial risk profile (PIBD INTERMED), self-efficacy (IBD-SES-A), function (IBD-DI), transition readiness (TRAQ) and IBD knowledge (IBD-KID2), and depression, anxiety and activation. Core Component 2: Transition Navigator: Participants will be assigned a transition navigators, who will have knowledge of IBD, an understanding of the care pathway involved in transitioning IBD patients, and the skills and ability to provide psychosocial support. Core Component 3: Participant Skills-building: Skills-building materials delivered virtually. Navigators will also be trained as motivational coaches and will lead separate personalized virtual sessions targeting individual skills that have been identified as deficient during the assessment phase. Core Component 4: eLearning Curriculum: Organized online eLearning modules with reinforcement of knowledge by the navigators.
Intervention Type
Behavioral
Intervention Name(s)
Standard of care
Other Intervention Name(s)
Control
Intervention Description
The control group will be provided a standardized version of routine care for transition. In addition to recruiting centers' standard of care, all participating centers will implement the following transition interventions: A written letter explaining the goals of transition to the patient and family. Completion of age-appropriate checklists to ensure adolescents are meeting milestones of transition (developed by the TRACC Network).51 Annual online live educational webinars on transition and adolescent issues (hosted by the CIDsCaNN Education Committee). Completion of the Pediatric INTERMED,52 with appropriate biopsychosocial intervention. Completion of a transfer-of-care summary letter sent to the receiving adult gastroenterologist using a standardized letter template.53 The Control Group may also receive any interventions currently in place in their participating care center, but will not receive the formal 4-component intervention described below.
Primary Outcome Measure Information:
Title
IBD Disability Index (IBD-DI)
Description
Ordinal variable that measures participant functioning as the primary outcome. IBD-DI was selected as a validated measure of overall disability, functioning, and health. The primary outcome will be measured 3 years after enrollment.
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Transition Readiness Assessment Questionnaire (TRAQ)
Description
Transition Readiness
Time Frame
3 years
Title
Transition Readiness Assessment Questionnaire (TRAQ)
Description
Transition Readiness
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
Transition Success Scores (TSS)
Description
Transition Readiness
Time Frame
3 years
Title
Transition Success Scores (TSS)
Description
Transition Readiness
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
Pediatric IBD INTERMED
Description
Biopsychosocial Risk Profile
Time Frame
3 years
Title
Pediatric IBD INTERMED
Description
Biopsychosocial Risk Profile
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
IBD-KID2
Description
Disease-related knowledge
Time Frame
3 years
Title
IBD-KID2
Description
Disease-related knowledge
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
IBDQ-32
Description
Quality of life
Time Frame
3 years
Title
IBDQ-32
Description
Quality of life
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
IBD Self-Efficacy Scale - Adolescent (IBD-SES-A)
Description
Self-Efficacy
Time Frame
3 years
Title
IBD Self-Efficacy Scale - Adolescent (IBD-SES-A)
Description
Self-Efficacy
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
Physician Global Assessment (PGA)
Description
Physician assessment of disease activity
Time Frame
3 years
Title
Physician Global Assessment (PGA)
Description
Physician assessment of disease activity
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
Fecal calprotectin
Description
Measure of gut inflammation
Time Frame
3 years
Title
Modified Harvey-Bradshaw Index (HBI) for Crohn's disease
Description
Disease activity in Crohn's disease patients
Time Frame
3 years
Title
Modified Harvey-Bradshaw Index (HBI) for Crohn's disease
Description
Disease activity in Crohn's disease patients
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
Pediatric Ulcerative Colitis Activity Index (PUCAI)
Description
Disease activity in ulcerative colitis patients
Time Frame
3 years
Title
Pediatric Ulcerative Colitis Activity Index (PUCAI)
Description
Disease activity in ulcerative colitis patients
Time Frame
Up to 24 months (at time of transfer to adult care)
Title
Emergency department visit after 18th birthday (yes/no)
Description
Health services utilization
Time Frame
3 years
Title
Number of emergency department visits after 18th birthday
Description
Health services utilization
Time Frame
3 years
Title
Hospitalization after 18th birthday (yes/no)
Description
Health services utilization
Time Frame
3 years
Title
Number of outpatient visits to a gastroenterologist after 18th birthday
Description
Health services utilization
Time Frame
3 years
Title
IBD Disability Index (IBD-DI)
Description
Ordinal variable that measures participant functioning as the primary outcome. IBD-DI was selected as a validated measure of overall disability, functioning, and health.
Time Frame
Up to 24 months (at time of transfer to adult care)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged 16-17.5 years Diagnosed with IBD diagnosed using standard criteria Ability to speak/read English at a functional (Grade 8) level Intention to reside in Canada after transfer to adult care Ability to use a smartphone or personal computer for the virtual intervention Exclusion Criteria: Do not speak English fluently Intention to leave Canada after graduation from high school
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Eric I Benchimol, MD, PhD
Phone
613-813-1500
Email
eric.benchimol@sickkids.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Jacqueline de Guzman
Phone
416-920-5035
Ext
234
Email
jdeguzman@crohnsandcolitis.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Eric I Benchimol, MD, PhD
Organizational Affiliation
The Hospital for Sick Children
Official's Role
Principal Investigator
Facility Information:
Facility Name
BC Children's Hospital
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V6H 3N1
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gloria Yu
Email
gloria.yu2@cw.bc.ca
First Name & Middle Initial & Last Name & Degree
Zahra Jama Hussein
Email
zahra.shire@cw.bc.ca
First Name & Middle Initial & Last Name & Degree
Sally Lawrence, MD
Facility Name
McMaster Children's Hospital
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 1H4
Country
Canada
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Katherine Prowse, MD
Phone
905-521-2100
Email
prowsk@mcmaster.ca
First Name & Middle Initial & Last Name & Degree
Katherine Prowse, MD
Facility Name
Children's Hospital of Eastern Ontario
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1H 8L1
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Shefali Sikka Kehar
Phone
613-737-7600
Email
SSikkaKehar@cheo.on.ca
First Name & Middle Initial & Last Name & Degree
David R Mack, MD
Facility Name
The Hospital for Sick Children
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X8
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Claudia Tersigni
Phone
416-813-1500
Email
claudia.tersigni@sickkids.ca
First Name & Middle Initial & Last Name & Degree
Eric I Benchimol, MD, PhD
First Name & Middle Initial & Last Name & Degree
Anne M Griffiths, MD
First Name & Middle Initial & Last Name & Degree
Thomas D Walters, MD, MSc

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Location of the repository - OSF.io or journal (planned) Administrators for the repository Since we are not sure which journals we will submit to at this time, we cannot comment on the location/administrators for the repository. De-identified study data plans - At a minimum, research journals are asking that authors share a 'minimal data set' for submission. This is normally defined as the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods. This is what will be shared with journals upon submission. Privacy protections for stored study data - Only de-identified study data will be shared with the open access repository. Submission to research journals has been outlined on the participant consent form.
Citations:
PubMed Identifier
35585484
Citation
Bollegala N, Barwick M, Fu N, Griffiths AM, Keefer L, Kohut SA, Kroeker KI, Lawrence S, Lee K, Mack DR, Walters TD, de Guzman J, Tersigni C, Miatello A, Benchimol EI. Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trial. BMC Gastroenterol. 2022 May 18;22(1):251. doi: 10.1186/s12876-022-02307-9.
Results Reference
derived

Learn more about this trial

Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care

We'll reach out to this number within 24 hrs